| Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer (NCT04981509) | National Cancer Institute (NCI) | 2022-06-10 |
| Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (NCT04603365) | Jonsson Comprehensive Cancer Center | 2021-10-18 |
| Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC (NCT04413123) | Bradley A. McGregor, MD | 2020-11-05 |
| Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study (NCT04071223) | National Cancer Institute (NCI) | 2020-07-29 |
| An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy (NCT04623502) | University of Texas Southwestern Medical Center | 2019-09-30 |
| A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma (NCT03635892) | Memorial Sloan Kettering Cancer Center | 2018-08-13 |
| Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study (NCT06339138) | Mayo Clinic | 2018-06-27 |
| Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma (NCT03541902) | M.D. Anderson Cancer Center | 2018-05-15 |
| A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma (NCT02837991) | Celldex Therapeutics | 2016-06-01 |
| Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma (NCT02489695) | Centre Leon Berard | 2015-10-01 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer (NCT01767636) | Mayo Clinic | 2013-05-16 |
| Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors (NCT00335556) | Children's Oncology Group | 2006-06-01 |
| Study of Kidney Tumors in Younger Patients (NCT00898365) | Children's Oncology Group | 2006-02-27 |
| Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer (NCT00126503) | National Cancer Institute (NCI) | 2005-05-01 |
| Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT00098618) | National Cancer Institute (NCI) | 2004-10-01 |